Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providersHendrée E. Jones, Andreea A. Creanga, Mark L. Hudak et al.|American Journal of Obstetrics and Gynecology|2013Cited by 118
Antiemetic use among pregnant women in the United States: the escalating use of ondansetronLockwood G. Taylor, Sengwee Toh, Katherine Haffenreffer et al.|Pharmacoepidemiology and Drug Safety|2017Cited by 63
First-Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. PregnanciesSteven T. Bird, Ira Krefting, Corinne Woods et al.|Radiology|2019Cited by 56
A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selectionKate Gelperin, Leyla Şahin, Kira Leishear et al.|Pharmacoepidemiology and Drug Safety|2016Cited by 50
Risk of fetal or neonatal death or neonatal intensive care unit admission associated with gadolinium magnetic resonance imaging exposure during pregnancyAlmut G. Winterstein, Sonja A. Rasmussen, Sabina O. Nduaguba et al.|American Journal of Obstetrics and Gynecology|2022Cited by 42